Prospective Trial to Reduce Morbidity and Mortality After Lung Surgery in Patients With Reduced Pulmonary Capacity

Sponsor
University of Ulm (Other)
Overall Status
Unknown status
CT.gov ID
NCT00530491
Collaborator
Heidelberg University (Other)
90
1
2
13
6.9

Study Details

Study Description

Brief Summary

A fast track recovery program (thoracic epidural anesthesia, carbohydrate drink preoperative, early removal of chest tubes) is evaluated compared to conventional perioperative treatment (patient controlled analgesia, no carbohydrate drink preoperative) in patients with FEV1 < 70% of expected value or < 1.5L who undergo resections of the lung.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Fast track lung surgery
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Prospective Randomized Controlled Trial to Reduce Morbidity and Mortality After Lung Surgery in Patients With FEV1 < 70% of Expected Value or < 1.5L
Study Start Date :
Sep 1, 2007
Anticipated Primary Completion Date :
Sep 1, 2008
Anticipated Study Completion Date :
Oct 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 1

conventional perioperative management for lung surgery

Procedure: Fast track lung surgery
fast track lung surgery: carbohydrate drink preoperatively, PCEA, early removal of chest tube conventional: no carbohydrate drink preoperatively, ICB+PCA, removal of chest tube depending upon chest x-ray

Experimental: 2

fast track management for lung surgery

Procedure: Fast track lung surgery
fast track lung surgery: carbohydrate drink preoperatively, PCEA, early removal of chest tube conventional: no carbohydrate drink preoperatively, ICB+PCA, removal of chest tube depending upon chest x-ray

Outcome Measures

Primary Outcome Measures

  1. pulmonary complications (air leak, atelectasis, pneumonia); lung function on pod 7; overall mortality [1 year]

Secondary Outcome Measures

  1. duration of ICU treatment [1 year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • resection of the lung

  • FEV1 <70% of expected value or below 1.5L

  • 18-80y

  • given written informed consent

Exclusion Criteria:
  • contraindication for epidural anesthesia

  • prio ipsilateral thoracotomy

  • chemotherapy <6 weeks prior to study enter

  • existing pneumonia (fever, elevated WCC, elevated CRP)

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Ulm Ulm Germany 89075

Sponsors and Collaborators

  • University of Ulm
  • Heidelberg University

Investigators

  • Study Chair: Bernd M Muehling, M.D.,

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00530491
Other Study ID Numbers:
  • BM 140/07
First Posted:
Sep 17, 2007
Last Update Posted:
Feb 14, 2008
Last Verified:
Sep 1, 2007
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 14, 2008